Suzhou Abogen Biosciences Co., Ltd. – Trademark Portfolio
Entity Type: 99
Suzhou Abogen Biosciences Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ABOGEN and ABOGENBIO.
Unit 501, Building B1,
No.218 Xinghu Street, Suzhou IndustrialP
Showing of trademarks Trademarks
Trademark Classifications
Suzhou Abogen Biosciences Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Suzhou Abogen Biosciences Co., Ltd. have?
Suzhou Abogen Biosciences Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Suzhou Abogen Biosciences Co., Ltd. file in?
Suzhou Abogen Biosciences Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Suzhou Abogen Biosciences Co., Ltd.'s most well-known trademarks?
Suzhou Abogen Biosciences Co., Ltd.'s registered trademark portfolio includes well-known marks such as ABOGEN and ABOGENBIO. These are among 2 currently registered trademarks in the portfolio.
What is Suzhou Abogen Biosciences Co., Ltd.'s trademark registration success rate?
Suzhou Abogen Biosciences Co., Ltd. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.